The central hypothesis of this study was that p53 may act as a transcriptional regulator of SLC7A11, whereby the loss or mutation of p53 in brain tumors should show reduced SLC7A11 expression as well as reduced cystine–glutamate transport activity. Here, TP53 is linked to brain neoplasm.